- Home
- INBK vs TSHA Comparison
INBK vs TSHA Comparison
Compare INBK & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBK
- TSHA
- Stock Information
- Founded
- INBK 1999
- TSHA 2019
- Country
- INBK United States
- TSHA United States
- Employees
- INBK N/A
- TSHA N/A
- Industry
- INBK Major Banks
- TSHA Biotechnology: Pharmaceutical Preparations
- Sector
- INBK Finance
- TSHA Health Care
- Exchange
- INBK Nasdaq
- TSHA Nasdaq
- Market Cap
- INBK 228.1M
- TSHA 262.4M
- IPO Year
- INBK N/A
- TSHA 2020
- Fundamental
- Price
- INBK $21.02
- TSHA $1.76
- Analyst Decision
- INBK Buy
- TSHA Strong Buy
- Analyst Count
- INBK 4
- TSHA 8
- Target Price
- INBK $40.50
- TSHA $6.63
- AVG Volume (30 Days)
- INBK 77.5K
- TSHA 2.7M
- Earning Date
- INBK 04-23-2025
- TSHA 05-13-2025
- Dividend Yield
- INBK 1.14%
- TSHA N/A
- EPS Growth
- INBK 27.37
- TSHA N/A
- EPS
- INBK 2.40
- TSHA N/A
- Revenue
- INBK $114,609,000.00
- TSHA $8,333,000.00
- Revenue This Year
- INBK $3.03
- TSHA N/A
- Revenue Next Year
- INBK $16.38
- TSHA N/A
- P/E Ratio
- INBK $8.49
- TSHA N/A
- Revenue Growth
- INBK 20.13
- TSHA N/A
- 52 Week Low
- INBK $20.01
- TSHA $1.05
- 52 Week High
- INBK $43.26
- TSHA $4.32
- Technical
- Relative Strength Index (RSI)
- INBK 33.55
- TSHA 61.26
- Support Level
- INBK $21.76
- TSHA $1.13
- Resistance Level
- INBK $26.83
- TSHA $1.98
- Average True Range (ATR)
- INBK 1.73
- TSHA 0.16
- MACD
- INBK -0.10
- TSHA 0.08
- Stochastic Oscillator
- INBK 9.00
- TSHA 76.34
About INBK First Internet Bancorp
First Internet Bancorp is a bank holding company. Through its subsidiaries, it provides commercial real estate (CRE) lending, including nationwide single tenant lease financing and commercial and industrial (C&I) lending, including business banking/treasury management services. The company offers its products and services through the internet and does not have any branches. With operations organized into a single segment called the Commercial Banking segment, it also provides retail banking services.
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.